Xiangxue Pharmaceutical Cash Flow-to-Debt Ratio
Xiangxue Pharmaceutical cash flow-to-debt ratio. Xiangxue Pharmaceutical (300147) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of CN¥75.64 Million could theoretically repay 0% of its total liabilities (CN¥6.27 Billion) in one year. Check 300147 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Xiangxue Pharmaceutical (2007–2025)
Cash flow-to-debt ratio of Xiangxue Pharmaceutical from 2007 to 2025. Historical debt coverage capacity for Xiangxue Pharmaceutical across 19 annual periods. Check 300147 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Xiangxue Pharmaceutical Cash Flow-to-Debt Ratio by Year (2007–2025)
Xiangxue Pharmaceutical cash flow-to-debt ratio by year from 2007 to 2025. Year-by-year debt coverage analysis for Xiangxue Pharmaceutical. For the full cash flow conversion analysis, see Xiangxue Pharmaceutical operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | CN¥139.63 Million | CN¥6.70 Billion | ▲ +594.7% |
| 2024 | 0.00x | CN¥18.17 Million | CN¥6.06 Billion | ▼ -93.2% |
| 2023 | 0.04x | CN¥263.44 Million | CN¥5.97 Billion | ▲ +26.9% |
| 2022 | 0.03x | CN¥227.38 Million | CN¥6.53 Billion | ▲ +3.0% |
| 2021 | 0.03x | CN¥257.56 Million | CN¥7.62 Billion | ▼ -27.4% |
| 2020 | 0.05x | CN¥257.18 Million | CN¥5.53 Billion | ▲ +143.9% |
| 2019 | 0.02x | CN¥83.02 Million | CN¥4.35 Billion | ▼ -3.5% |
| 2018 | 0.02x | CN¥91.24 Million | CN¥4.61 Billion | ▲ +0.3% |
| 2017 | 0.02x | CN¥109.53 Million | CN¥5.56 Billion | ▼ -57.3% |
| 2016 | 0.05x | CN¥198.48 Million | CN¥4.30 Billion | ▼ -68.1% |
| 2015 | 0.14x | CN¥159.89 Million | CN¥1.11 Billion | ▲ +49.9% |
| 2014 | 0.10x | CN¥165.58 Million | CN¥1.72 Billion | ▼ -48.2% |
| 2013 | 0.19x | CN¥328.37 Million | CN¥1.76 Billion | ▲ +121.0% |
| 2012 | 0.08x | CN¥118.91 Million | CN¥1.41 Billion | ▲ +43.0% |
| 2011 | 0.06x | CN¥29.55 Million | CN¥502.16 Million | ▼ -38.4% |
| 2010 | 0.10x | CN¥45.47 Million | CN¥476.01 Million | ▼ -25.4% |
| 2009 | 0.13x | CN¥46.19 Million | CN¥360.69 Million | ▼ -18.4% |
| 2008 | 0.16x | CN¥55.72 Million | CN¥354.94 Million | ▼ -58.8% |
| 2007 | 0.38x | CN¥138.02 Million | CN¥361.98 Million | — |